The majority of secondary glioblastomas bear mutations of the genes encoding the tumor protein 53 (p53) and of isocitrate-dehydrogenase 1 (IDH-1), leading to the perception that these mutations are early, if not the earliest, steps in the development of these gliomas [7], [8]. The gene discussed is TP53; the disease is glioma.